Massachusetts Wealth Management »

AstraZeneca shares owned by Massachusetts Wealth Management

Quarter-by-quarter ownership of AstraZeneca (AZN) shares owned by Massachusetts Wealth Management from 13F filings

Historical chart of Massachusetts Wealth Management investment in AstraZeneca

Tip: Access up to 7 years of quarterly data

All positions including AstraZeneca held by Massachusetts Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in AstraZeneca by Massachusetts Wealth Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $226k 2.9k 77.91
2024-06-30 $226k 2.9k 77.99
2023-06-30 $208k 2.9k 71.57
2023-03-31 $201k 2.9k 69.41

More positions owned by Massachusetts Wealth Management

Select Sector Spdr Tr Technology (XLK)
Apple (AAPL)
JPMorgan Chase & Co. (JPM)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Microsoft Corporation (MSFT)
Exxon Mobil Corporation (XOM)
Select Sector Spdr Tr Financial (XLF)
Select Sector Spdr Tr Indl (XLI)
Bank of America Corporation (BAC)
Citigroup Com New (C)
Chevron Corporation (CVX)
NVIDIA Corporation (NVDA)
ConocoPhillips (COP)
Select Sector Spdr Tr Energy (XLE)
Ge Aerospace Com New (GE)

View all positions for Massachusetts Wealth Management

Top funds holding AstraZeneca

T. Rowe Price Associates
PRIMECAP Management Company
Capital Research and Management Company - Division 3
Wellington Management Company
Bank of America Corporation
FMR
Franklin Resources
Morgan Stanley
Jennison Associates
Sanders Capital
Fisher Investments
Goldman Sachs Group
Atlantic Trust
Citadel Advisors
Neuberger Berman Group

View all funds holding AstraZeneca